In the context of breast cancer, we previously identified enriched E2F1 and MYC binding sites in the L1PA2 subfamily, and demonstrated that L1PA2 contributed the significant promoter activity for the SYT1 oncogene in triple negative breast cancer cell lines35. This evidence concerns the gene SYT1 and triple-negative breast carcinoma.